Commonwealth Equity Services’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05M | Buy |
113,512
+1,852
| +2% | +$17.1K | ﹤0.01% | 2521 |
|
|
2025
Q1 | $958K | Buy |
111,660
+8,998
| +9% | +$77.2K | ﹤0.01% | 2494 |
|
|
2024
Q4 | $1.1M | Buy |
102,662
+7,285
| +8% | +$78.3K | ﹤0.01% | 2317 |
|
|
2024
Q3 | $542K | Buy |
95,377
+844
| +0.9% | +$4.8K | ﹤0.01% | 2832 |
|
|
2024
Q2 | $399K | Buy |
94,533
+963
| +1% | +$4.07K | ﹤0.01% | 3034 |
|
|
2024
Q1 | $476K | Buy |
93,570
+1,780
| +2% | +$9.06K | ﹤0.01% | 2859 |
|
|
2023
Q4 | $855K | Buy |
91,790
+8,557
| +10% | +$79.7K | ﹤0.01% | 2279 |
|
|
2023
Q3 | $545K | Sell |
83,233
-4,762
| -5% | -$31.2K | ﹤0.01% | 2522 |
|
|
2023
Q2 | $715K | Buy |
87,995
+225
| +0.3% | +$1.83K | ﹤0.01% | 2343 |
|
|
2023
Q1 | $752 | Sell |
87,770
-3,245
| -4% | -$28 | ﹤0.01% | 2236 |
|
|
2022
Q4 | $842K | Buy |
91,015
+8,640
| +10% | +$79.9K | ﹤0.01% | 2076 |
|
|
2022
Q3 | $850K | Buy |
82,375
+285
| +0.3% | +$2.94K | ﹤0.01% | 2017 |
|
|
2022
Q2 | $821K | Buy |
82,090
+2,250
| +3% | +$22.5K | ﹤0.01% | 2053 |
|
|
2022
Q1 | $982K | Buy |
79,840
+5,416
| +7% | +$66.6K | ﹤0.01% | 2014 |
|
|
2021
Q4 | $1.29M | Buy |
74,424
+32,109
| +76% | +$557K | ﹤0.01% | 1809 |
|
|
2021
Q3 | $759K | Buy |
42,315
+546
| +1% | +$9.79K | ﹤0.01% | 2147 |
|
|
2021
Q2 | $954K | Buy |
41,769
+4,340
| +12% | +$99.1K | ﹤0.01% | 1946 |
|
|
2021
Q1 | $559K | Sell |
37,429
-6,621
| -15% | -$98.9K | ﹤0.01% | 2242 |
|
|
2020
Q4 | $237K | Buy |
44,050
+11,820
| +37% | +$63.6K | ﹤0.01% | 2775 |
|
|
2020
Q3 | $146K | Buy |
32,230
+453
| +1% | +$2.05K | ﹤0.01% | 2811 |
|
|
2020
Q2 | $156K | Sell |
31,777
-300
| -0.9% | -$1.47K | ﹤0.01% | 2682 |
|
|
2020
Q1 | $101K | Buy |
32,077
+2,100
| +7% | +$6.61K | ﹤0.01% | 2581 |
|
|
2019
Q4 | $77K | Buy |
29,977
+1,792
| +6% | +$4.6K | ﹤0.01% | 2765 |
|
|
2019
Q3 | $89K | Buy |
28,185
+6,157
| +28% | +$19.4K | ﹤0.01% | 2691 |
|
|
2019
Q2 | $74K | Buy |
22,028
+1,515
| +7% | +$5.09K | ﹤0.01% | 2662 |
|
|
2019
Q1 | $62K | Sell |
20,513
-200
| -1% | -$604 | ﹤0.01% | 2649 |
|
|
2018
Q4 | $32K | Buy |
20,713
+5,893
| +40% | +$9.1K | ﹤0.01% | 2600 |
|
|
2018
Q3 | $40K | Buy |
14,820
+2,000
| +16% | +$5.4K | ﹤0.01% | 2706 |
|
|
2018
Q2 | $34K | Buy |
12,820
+650
| +5% | +$1.72K | ﹤0.01% | 2687 |
|
|
2018
Q1 | $33K | Buy |
12,170
+1,695
| +16% | +$4.6K | ﹤0.01% | 2623 |
|
|
2017
Q4 | $34K | Sell |
10,475
-1,000
| -9% | -$3.25K | ﹤0.01% | 2583 |
|
|
2017
Q3 | $48K | Buy |
+11,475
| New | +$48K | ﹤0.01% | 2472 |
|